Crafting a genomics strategy early is key for successful oncology drug development

An historic shift towards treating cancer based on a tumor’s genetics rather than its site of origin is underway. Genomically-targeted drugs, properly developed, have an inherent advantage over drugs that are not. But the success of any one will depend on good strategic planning, done early. Read about three key considerations for crafting a successful genomic biomarker strategy.

Previous Flipbook
Parexel Biotech oncology project experience
Parexel Biotech oncology project experience

Next Flipbook
Infographic: Top 10 myths about working with FDA for oncology drug approval
Infographic: Top 10 myths about working with FDA for oncology drug approval

×

Lets start a conversation...

First Name
Last Name
Job Title
Company Name
Country
Therapeutic Area Interest - optional
Tell us how we can help
Thank you! We'll be in touch soon.
Error - something went wrong!